Figure 2 from CAR T-cell Kinetics, Persistence, and Clinical Outcomes in Adult Patients with Relapsed/Refractory B-cell ALL Treated with Obecabtagene Autoleucel in the FELIX Study
Authors:
- Claire RoddieCRClaire Roddie
- William DayWDWilliam Day
- Meera RaymondMRMeera Raymond
- Deborah CluxtonDCDeborah Cluxton
- Jason CaulfieldJCJason Caulfield
- Heather Dainton-SmithHDHeather Dainton-Smith
- Brooke McElweeBMBrooke McElwee
- Yanqing HuYHYanqing Hu
- Karamjeet S. SandhuKSKaramjeet S. Sandhu
- Eleni TholouliETEleni Tholouli
- Aaron C. LoganALAaron C. Logan
- Paul ShaughnessyPSPaul Shaughnessy
Open Access
- 15 July 2026
- other
- Published by American Association for Cancer Research (AACR)